Terminated OBSERVATIONAL NCT00178542

Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle

Changes in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle

Sponsor: The University of Texas Health Science Center, Houston

Updated 7 times since 2017 Last updated: May 3, 2013 Started: Sep 30, 2005 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient enrollment

This observational or N/A phase trial investigates Von Willebrand Disease and is currently terminated or withdrawn. The University of Texas Health Science Center, Houston leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Terminated
Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jun 2018 — Jan 2021 [monthly]

Terminated

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Terminated

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Terminated NA

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The University of Texas Health Science Center, Houston
The ZLB Behring Foundation

Data source: The University of Texas Health Science Center, Houston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States